Control Bionics Ltd. ( ($AU:CBL) ) just unveiled an announcement. Control Bionics has completed the acquisition of 100% of U.S.-based Neuro Elite ...

Control Bionics Ltd. ( ($AU:CBL) ) has shared an update. Control Bionics Limited has lodged a notice with the ASX for a proposed issue of up to ...

MILFORD, Ohio and NEW SOUTH WALES, Australia, April 8, 2021 /PRNewswire/ — Control Bionics, a global assistive technology company specializing in speech generating devices, announced it is partnering ...

Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd. has presented its next-generation assistive technology and data measurement solutions, aiming to enhance user experience and ...

Revenue: AU$6.14m (up 15% from FY 2024). Net loss: AU$6.11m (loss widened by 3.3% from FY 2024). AU$0.023 loss per share. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% ...

Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd is set to showcase its innovative medical devices at the Coffee Microcaps Morning Meeting with CEO Jeremy Steele leading the ...

But investors are well aware of the potential, having pushed Control Bionics shares up as much as 90% yesterday. A developer of augmentative and alternative communication (AAC) technology, Control ...

PERTH, Australia – Med-tech company Control Bionics began trading on the Australian Securities Exchange (ASX:CBL) Dec. 7 in an IPO that saw the company raise AU$15 million (US$11.25 million).